Ray-Coquard Isabelle
@CoquardRay
Followers
597
Following
674
Media
15
Statuses
518
oncologie médicale Centre Léon Berard Université Claude Bernard
Lyon, France
Joined December 2013
🌍 11 février - Journée mondiale des malades 🔬 Depuis 30 ans, ARCAGY-GINECO est un acteur clé de la #recherche clinique et translationnelle en onco-gynéco. Nous améliorons la prise en charge des patientes en coordonnant des essais cliniques en France et à l’international. À
0
1
1
Two papers. On the left, a non-randomized, non-crossover study showing that a one-off sauna exposure significantly decreased arterial stiffness, with implications on cardiovascular health. On the right, a randomized, crossover (more robust) study, showing no benefits on
71
823
3K
New guidelines for uterine sarcomas!!!🎉 @IJGConline @IJGCfellows @ESGO_society @ENYGO_official @Biruniedu @BiruniKutuphane
🚨 New ESGO/EURACAN/GCIG guidelines for uterine sarcomas! Key updates: • #Expert centers crucial for #diagnosis & #treatment • Advanced imaging & #molecular tests recommended • Tailored surgical & systemic approaches Read & share these #practice-changing #guidelines @
0
4
18
📢 📰 The GINECO randomized phase II study #Neopembrov has just been #published together with the #translational #research in NATURE COMMUNICATION.
0
3
4
ROCSAN Part I Study Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma @CoquardRay @myESMO #ESMOGynae24 #gyncsm
onclive.com
ROCSAN step 1 did not meet its primary end point of 16-week response rate with niraparib or dostarlimab/niraparib in endometrial/ovarian carcinosarcoma.
0
2
0
Congrats @jeanyvesblay & colleagues of #FrenchSarcomaGroup for completing study of #6vs3years of #adjuvant #imatinib 💊i n pts w/ #highrisk #GISTs. Presented at @myESMO @AACR #virtualplenary over last #2days with #specific discussions from #APAC #discussants as well!
1
7
30
Apply now for the #ESMOPreceptorship on #UterineCancer: multidisciplinary management, standards of care, therapeutic targets and future perspectives. 🌏 Lugano (CH), 11-12 July 2024. 📍 Deadline to apply: 06 May 2024. https://t.co/hc1X4SC9OK
@Ilaria_Colombo_ @CoquardRay #GynCSM
0
2
6
[LES SEANCES DE L'ANM] 🔴Suivez en direct la séance de demain à 14h30 « Avancées dans le #cancer de l’#Ovaire : vers une #guérison ? » @ICO_cancer @CLCCJeanPERRIN @CLCCLeonBerard ➡️ https://t.co/stiNrJbUCX
0
1
2
Latest @ESMO_Open podcast 📢 First-line maintenance treatment of high grade serous #OvarianCancer with a BRCA1/2 mutation, with Margherita Turinetto, @CoquardRay & Charlie Gourley. https://t.co/uRWUmygVT1
#GynCSM
0
6
21
The new uterine sarcoma guidelines are ready to present at #ESGO2024 in Barcelona! The guidelines working group, which is a collaboration between ESGO, @ERN_EURACAN and GCIG, held its last meeting in Milan 🇮🇹 this week at L'Istituto Nazionale dei Tumori to finalize the
0
10
29
Starting at 18h CET today ‼️ The #GynOnc sessions of the OncoAlert Colloquium! Don’t miss @OncoAlert 's free, multidisciplinary event. 🙌 The ESGO speakers on #gynonc are: 🔸Nicole Concin 🇦🇹 🔸Isabelle Ray-Coquard @CoquardRay 🇫🇷 🔸Viola Heinzelmann-Schwartz 🇨🇭 🔸Nicolo
0
4
5
Teratoma in the primary tumor or in post-chemotherapy residual non-retroperitoneal disease is not associated with inferior survival in metastatic non-seminomatous germ cell tumors.
0
3
11
En cette #journéemondialecontrelecancer découvrez l’émission captivante Têtes Chercheuses en replay. Plongez dans l’univers des chercheurs dévoués à l origine des percées scientifiques qui façonnent l’avenir de la lutte contre le cancer. https://t.co/cMNPGoVER1
#WorldCancerDay
0
3
5
▶️ Live : Cours St Paul de Vence - Cannes 2024 La session GINECO a démarré ! Au programme de l'après-midi : les nouveautés dans le cancer du col et de l'endomètre ainsi qu'un point sur les traitements et avancées dans les #cancers de la vulve et de l'ovaire.
0
2
4
📣 @jeanyvesblay, Scientific Co-Chair, invites you to register for #ESMOSarcomaAndRareCancers24 (14-16 Mar). Whatever your #RareCancer specialisation, you will be sure to find topics of interest to you at this important event. Register now 👉 https://t.co/DhWz3bhKQm
#sarcoma
0
10
29
❗ SAVE THE DATE !! Réunion régionale FEM-NET Lieu : Novotel Lyon Bron Eurexpo Horaires : 18h-21h Et aussi à 13h30 la plénière Sein/Gynécologie d'@onco_aura Inscription gratuite et obligatoire. Places limitées 👉 https://t.co/prR8jgiaVX
0
4
2
Don’t miss today’s #ESMOVirtualPlenary session to stay up to date with the latest, original data in #cervicalcancer. ⏰ Today(3 Nov) at 18:30 CET. Full programme: https://t.co/XeUzZFpdV3
@GEICOgroup @CoquardRay #GYNSM
1
6
24
Francois Gouin: sarcoma surgeon in CLB Unicancer and FSG- starts today his global solo race around the world without assistance! HORN, GOOD HOPE, and LEUWIN beware! SOOO PROUD!!!!
0
10
53
@seppobauer @breelynwilkyMD @CoquardRay @SilviaStacchia @RobinL_Jones @ViktorGruenwald I echo @seppobauer! very solid results of LMS-04, kudos to the investigators: 1st PFS and OS benefit in advanced #leiomyosarcoma is a milestone! We always wish to know more to put trial results into context and decipher the experimental arm:doxo-trabe+\-surgery+\-maintenance
1
1
3
💐The BOUQUET trial is a novel biomarker-directed platform trial in rare #OvarianCancer - so brilliant and allows seamless enrollment of #RareCancers #ESMO2023 #gyncsm
1
12
15